Skip to main content
Aurobindo Pharma Limited (BOM:524804)
India flag India · Delayed Price · Currency is INR
1,166.30
+9.20 (0.80%)
At close: Mar 27, 2025

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 79.79B INR in the quarter ending December 31, 2024, with 8.53% growth. This brings the company's revenue in the last twelve months to 309.22B, up 10.85% year-over-year. In the fiscal year ending March 31, 2024, Aurobindo Pharma had annual revenue of 290.02B with 16.68% growth.

Revenue (ttm)
309.22B
Revenue Growth
+10.85%
P/S Ratio
n/a
Revenue / Employee
11.89M
Employees
26,015
Market Cap
658.72B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020230.99B35.35B18.07%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,398.38B
HDFC Bank 2,702.59B
Tata Consultancy Services 2,520.82B
Bharti Airtel 1,627.08B
ICICI Bank 1,755.26B
State Bank of India 3,409.52B
Infosys 1,635.60B
Bajaj Finance 358.05B
Revenue Rankings

Aurobindo Pharma News

More News